ADT1108-Budigalimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1108 |
Product Name |
ADT1108-Budigalimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse PDCD1 antibody, anti-PDCD1 antibody, anti PDCD1 antibody, recombinant PDCD1, PDCD1 antibody, anti-PDCD1 monoclonal antibody, PDCD1 antibodies, PDCD1 recombinant antibody, PDCD1 blocking antibody, PD1 recombinant antibody, PD1 blocking antibody, CD279 recombinant antibody, CD279 blocking antibody |
|
Alias |
ABBV-181, PR-1648817 |
Host |
CHO Cells |
Species |
Human |
Target |
PDCD1/PD-1/CD279 |
Gene ID |
5133 |
Isotype |
IgG1 Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Cancer |
CAS Number |
2098225-93-3 |
Product Description |
Budigalimab is under investigation in clinical trial NCT04807972 (Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 Is Administered in Combination With IV Modified FOLFIRINOX (Mffx) With or Without IV Budigalimab Compared to Mffx in Adult Participants With Untreated Pancreatic Cancer Metastasis). |
Application |
Elisa, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Ma Y, et al. Zhonghua Yu Fang Yi Xue Za Zhi, 2023 Jun 6. PMID 37357205
2. Mirsharif ES, et al. Int Immunopharmacol, 2023 Jun. PMID 37172423
3. Tarique M, et al. Front Immunol, 2023. PMID 37153623
|